Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines

Cancer Research

Volumn 56, Issue 5, 1996, Pages 1056-1062

  Kazmi, Syed M I ^a   Plante, Richard K ^a   Visconti, Vito ^a   Lau, Catherine Y ^a  

^a Discovery Research   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FENRETINIDE; PROMEGESTONE; RETINOIC ACID; RETINOIC ACID RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; DRUG ACTIVITY; DRUG EFFECT; GENE ACTIVATION; GENE EXPRESSION; GENE TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL DIVISION; FEMALE; FENRETINIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATOLYTIC AGENTS; RECEPTORS, RETINOIC ACID; RETINOBLASTOMA PROTEIN; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0030062307     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Moon, R. C., Mehta, R. G , and Detrisac, C. J Retinoids as chemopreventive agents for breast cancer. Cancer Detect Prev., 16. 73-79, 1992.
2. Costa, A , Formelli, F., Chiesa, F., Decensi, A., De Palo, G , and Veronesi, U. Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide Cancer Res. (Suppl.), 54: 2032s-2037s, 1994.
3. Costa, A., Malone, W., Perloff, M., Buranelli, F., Campa, T , Dossena, G., Magni, A , Pizzichetta, M., Andreoli, C., Del Vecchio, M., Formelli, F., and Barbieri, A. Tolerabihty of the synthetic retinoid fenretinide (HPR), Eur. J. Cancer Clin. Oncol , 25: 805-808, 1989
4. Moon, R. C , Pritchard, J. F , Mehta, R. G , Nomides, C. T , Thomas, C F , and Dinger, N M. Suppression of rat mammary cancel development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumour. Carcinogenesis (Lond.), 10. 1645-1649, 1989.
5. Pollard, M., Luckert, P. H , and Sporn, M B. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide. Cancer Res., 51: 3610-3611, 1991
6. Formelli, F. and Cleris, L Synthetic retinoid fenretinide is effective against a human ovarian carcinoma venograft and potentiates cisplatin activity Cancer Res., 53. 5374-5376, 1993
7. Mehta, R. G , Hultin, T. A , and Moon, R C. Metabolism of the chemopreventive retinoid N-(4-hydroxyphenyl)retinamide by mammary gland in organ culture Biochem. J , 256: 579-584, 1988
8. Modiano, M R., Dalton, W. S , Lippman, S M., Joffe, L , Booth, A R , and Meyskens, F. L., Jr Phase II study of fenretinide (N-(4-hydroxyphenyl)retinamide) in advanced breast cancer and melanoma. Invest. New Drugs, 8: 317-319, 1990.
9. Veronesi, U., De Palo, G , Costa, A., Formelli, F , Marubini, E., and Del Vecchio, M. Chemoprevention of breast cancer with retinoids. Monogr Natl Cancer Inst , 12. 93-97, 1992.
10. Chiesa, F , Tradati, N., Marazza, M , Rossi, N., Boracchi, P , Mariani, L., Clerici, M , Formelli, F , Barzan, L., Carrassi, A , Pastorini, A., Camerini, T , Giardini, R , Zurrida, S , Minn, F L , Costa, A , De Palo, G., and Veronesi, U. Prevention of local relapses and new localizations of oral leukoplakias with the synthetic retinoid fenretinide (4-HPR). Preliminary results Eur. J. Cancer, 28B. 97-102, 1992.
11. Giguere, V., Ong, E. S , Segui, P , and Evans, R. M. Identification of a receptor for the morphogen retinoic acid. Nature (Lond.), 330: 624-629, 1987.
12. Petkovich, M., Brand, N. J , Krust, A., and Chambon, P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature (Lond.), 330. 444-450, 1987.
13. Krust, A., Kastner, P., Petkovich, M., Zelent, A., and Chambon, P. A third human retinoic acid receptor. hRAR-γ. Proc Natl. Acad. Sci. USA, 86: 5310-5314, 1989.
14. Zhang, X-K., Hoffmann, B., Tran, P. B-V , Graupner, G., and Pfahl, M. Retinoic X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature (Lond.), 555: 441-446, 1992.
15. Heyman, R. A., Mangelsdorf, D. J., Dyck, J. A., Stein, R. B., Eichele, G., Evans, R. M., and Thaller, C. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell, 68: 397-406, 1992.
16. Berni, R., and Formelli, F. In vitro interaction of fenretinide with plasma retinol- binding protein and its functional consequences. FEBS Lett., 308: 43-45, 1992.
17. Fontana, J A., Burrows-Mezu, A., Cooper, B. N., and Miranda, D. Retinoid modulation of estradiol-stimulated growth and of protein synthesis and secretion in human breast carcinoma cells. Cancer Res., 50: 1997-2002, 1990.
18. Van der Burg, B., van der Leede, B-J M , Kwakkenbos-Isbrucker, L., Salverda, S., de Laat, S. W., and van der Saag, P. T. Retinoic acid resistance of estradiol- independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol. Cell. Endocrinol., 91: 149-157, 1993.
19. Demirpence, E., Pons, M., Balaguer, P., and Gagne, D Study of an antiestrogenic effect of retinoic acid in MCF7 cells. Biochem. Biophys. Res Commun., 183. 100-106, 1992
20. Ratko, T. A., Detrisac, C J., Dinger, N. M., Thomas, C. F., Kelloff, G. J., and Moon, R. C. Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats. Cancer Res., 49. 4472-4476, 1989.
21. Decensi, A., Formelli, F., Torrisi, R., and Costa, A. Breast cancer chemoprevention: studies with 4-HPR alone and in combination with tamoxifen using circulating growth factors as potential surrogate endpoints. J. Cell. Biochem Suppl., 17G: 226-233, 1993.
22. Lee, E. Y., To, H , Shew, J. Y., Bookstein, R., Scully, P., and Lee, W. H. Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science (Washington DC), 241: 218-221, 1988.
23. Varley, J. M , Armour, J., Swallow, J. E., Jeffreys, A J , Ponder, B. A., T'Ang, A., Fung, Y. K., Brammar, W. J , and Walker, R. A. The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours. Oncogene, 4: 725-729, 1989.
24. Wang, N P., To, H., Lee, W-H., and Lee, E. Y-H. P Tumour suppressor activity of AB and p53 genes in human breast carcinoma cells. Oncogene, 8. 279-288, 1993.
25. Yamashita, H., Kobayashi, S., Iwase, H., Itoh, Y , Kuzushima, T., Iwata, H., Itoh, K., Naito, A., Yamashita, T., Masaoka, A., and Kimura, N. Analysis of oncogenes and tumour suppressor genes in human breast cancer. Jpn. J. Cancer Res., 84: 871-878, 1993.
26. Geradts, J , Hu, S X., Lincoln, C. E , Benedict, W. F., and Xu, H J. Aberrant RB gene expression in routinely processed, archival tumour tissues determined by three different anti-RB antibodies Int. J. Cancer, 58 161-167, 1994.
27. Slack, R. S., Hamel, P. A., Bladon, T. S., Gill, R. M. and McBurney, M. W. Regulated expression of the retinoblastoma gene in differentiating embryonal carcinoma cells. Oncogene, 8: 1585-1591, 1993
28. Igawa, M., Tanabe, T. Chodak, G. W., and Rukstalis, D. B. N-(4-hydroxyphenyl)retinamide induces cell cycle specific growth inhibition in PC3 cells Prostate, 24: 299-305, 1994.
29. Kazmi, S. M. I , Visconti, V., Plante, R. K., Ishaque, A., and Lau, C. Y Differential regulation of human progesterone receptor A and B form-mediated trans-activation by phosphorylation Endocrinology, 133: 1230-1238, 1993.
30. Kazmi, S M. I , Plante, R. K., Visconti, V , Taylor, G. R., Zhou, L , and Lau, C. Y. Suppression of NFκB activation and NFκB-dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase. J. Cell. Biochem., 57: 299-310, 1995.
31. Seed, B., and Sheen, J. Y. A simple phase-extraction assay for chloramphenicol acetyltransferase activity. Gene, 67: 271-277, 1988.
32. Peterson, G. L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem , 83: 346-356, 1977.
33. Hultin, T. A., Filla, M. S , and McCormick, D. L. Distribution and metabolism of the retinoid. N-(4-methoxyphenyl)-all-trans-retinamide: the major metabolite of N-(4-hydroxyphenyl)-all-trans-retinamide in female mice. Drug Metab. Dispos., 18. 175-179. 1990.
34. Delescluse, C., Cavey, M. T., Martin, B., Bernard, B. A , Reichert, U., Maignan, J , Darmon, M., and Shroot, B. Selective high affinity retinoic acid receptor α or β-γ ligands. Mol. Pharmacol., 40: 556-562, 1991.
35. 3 or antiestrogen to inhibit T-47D human breast cancer cell proliferation. J. Steroid Biochem. Mol. Biol. 39: 455-460, 1991.
36. Clarke, C. L , Graham, J., Roman, S. D., and Sutherland, R. L. Direct transcriptional regulation of the progesterone receptor by retinoic acid diminishes progestin responsiveness in breast cancer cell line T-47D. J. Biol. Chem., 266: 18969-18975, 1991.
37. Glick, A. B., Flanders, K. C , Danielpour, D., Yuspa, S. H., and Sporn, M. B. Retinoic acid induces transforming growth-factor-beta 2 in cultured keratinocytes and mouse epidermis. Cell Regul., 1. 87-97, 1989
38. Adamo, M. L., Shao, Z. M., Lanau, F., Chen, J. C., Clemmons, D. R., Roberts, C. T., Jr., LeRoith, D , and Fontana, J. A. Insulin-like growth factor-I (IGF-I) and retinoic acid modulation of IGF-binding proteins (IGFBPs): IGFBP-2, -3, and - 4 gene expression and protein secretion in a breast cancer cell line. Endocrinology, 131: 1858-1866, 1992.
39. Torrisi, R., Pensa, F., Orengo, M. A., Catsafados, E., Ponzani, P , Boccardo, F., Costa, A., and Decensi, A. The synthetic retinoid fenretinide lowers plasma insulin-like growth factor I levels in breast cancer patients. Cancer Res., 53: 4769-4771, 1993.
40. Delia, D., Aiello, A., Lombardi, L., Pelicci, P. G., Grignani, F., Grignani, F , Formelli, F , Menard, S., Costa, A., and Veronesi, U. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. Cancer Res., 53: 6036-6041, 1993.
41. Mariotti, A., Marcora, E., Burione, G , Costa, A., Veronesi, U., Pierotti, M. A., and Della Valle, G. N-(4-hydroxyphenyl)retinamide: a potent inducer of apoptosis in human neuroblastoma cells. J. Natl. Cancer Inst., 86. 1245-1247, 1994.
42. Martin, S. J , Bradley, J. G., and Cotter, T. G HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin. Exp. Immunol., 79: 448-453, 1990
43. Lipkin, S. H , Nelson, C. A , Glass, C. K., and Rosenfeld, M. A negative retinoic acid response element in the rat oxytocin promoter restricts transcriptional stimulation by heterologous transactivation domains. Proc. Natl. Acad. Sci. USA, 89: 1209-1213, 1992.
44. Fanjul, A., Dawson, M. I., Hobbs, P. D., Jong, L , Cameron, J. F., Harlev, E., Graupner, G., Lu, X. P., and Pfahl, M. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature (Lond ), 372. 107-111, 1994.
45. Zitnik, R J., Kotloff, R. M , Latifpour, J., Zheng, T , Whiting, N L., Schawlb, J., and Elias, J. A. Retinoic acid inhibition of IL-1-induced IL-6 production by human lung fibroblasts. J. Immunol , 152: 1419-1427, 1994.
46. Dillehay, D. L , Jiang, X L , and Lamon, E. W Differential effects of retinoids on pokeweed mitogen induced B-cell proliferation versus immunoglobulin synthesis. Int J. Immunopharmacol., 13: 1043-1048, 1991.
47. ElAttar, T. M. A., and Lin, H S. Effect of retinoids and carotenoids on prostaglandin formation by oral squamous carcinoma cells. Prostaglandins Leukotrienes Essent Fatty Acids, 43: 175-178, 1991
48. Swisshelm, K., Ryan, K., Lee, X., Tsou, H. C., Peacocke, M., and Sager, R Down-regulation of retinoic acid receptor β in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth & Differ., 5: 133-141, 1994.
49. Gewirtz, D. A DNA damage, gene expression, growth arrest and cell death. Oncol Res. 5. 397-408, 1993.